Statistics

Total Visits

Views
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study42

Select a period of time:

Number of views in the range

Views
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study26

Views

Views
January 20250
February 20255
March 202516
April 20252
May 20252
June 20251
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States4
Germany2
Brazil2
Spain1
Mexico1
 

Top cities views

Views
São Paulo2
Buffalo1
Council Bluffs1